Business, energy, technology, markets and global industry news from Business News Today

Kyowa Hakko USA

Pharma & Biotech

Cognizin citicoline enters neuromuscular research as Kirin reports early cell-model findings

Kirin’s Cognizin citicoline improved neuromuscular junction markers in cell models, opening a new research path that still needs human trials.

Read More
Pharma & Biotech

Can a postbiotic ingredient address screen-related eye fatigue in children? Kyowa Hakko’s commercial bet explained

Kyowa Hakko's Eyemuse postbiotic enters children's gummies with Zen Nutrients. We analyse the clinical evidence, regulatory gaps, and market implications. Read more.

Read More